Management Team

Management Team 2018-03-16T19:28:18+00:00

CSN Murthy

Chief Executive Officer

CSN began his career with ICICI Ventures, India’s first Venture Capital fund. He was subsequently a management consultant to the Pharma and Chemical sectors. Later, he worked in the Business Development and General Management functions in Pharmaceutical companies, including as the Chief Operating Officer of Gland Pharma Ltd. He holds a Bachelors degree in Chemical Engineering from the Indian Institute of Technology (IIT), Madras and an MBA from the Indian Institute of Management (IIM), Bangalore. CSN has led Aurigene since April 2005.

Murali Ramachandra, PhD

Chief Scientific Officer

Murali received his PhD from University of Idaho, USA and was a Postdoctoral fellow at DuPont Experimental Station and University of Kansas Medical Centre, Kansas City, USA. He has worked on various aspects of drug discovery at the National Institute of Health, USA and Schering-Plough, USA before joining Aurigene. He has co-authored more than 55 publications in peer-reviewed journals and is an inventor of 15 granted US patents. Murali has been in Aurigene since February 2005.

Chetan Pandit, PhD

Senior Vice President
Medicinal Chemistry

Chetan completed his BSc from St.Stephen’s College, Delhi and received his PhD from State University of New York, Buffalo. He has over 20 years of Medicinal Chemistry and Process research experience in the Industry, in India and Canada. He currently holds 10 patents, including one for a compound currently in Phase I/II clinical trials. Chetan has been in Aurigene since April 2007

Ashish Lath

Chief Finance Officer

Ashish is a Chartered Accountant (CA) with over 15 years of extensive experience across various finance, business planning and development functions. His earlier experience includes Deloitte & Mahindra and Mahindra. Prior to joining Aurigene, Ashish worked as CFO of Mahindra Reva Electric Vehicles.

Akhil Kumar, MBBS, MD, DM

Vice President
Clinical Development

Akhil has done his MBBS from AIIMS Delhi followed by Residency at SUNY, Brooklyn, NY and Fellowship in Hematology-Oncology at Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. He started his industry career as a Medical Director at GSK and was also one of the founding members of Oncology Analytics,  a start-up which drives cost effective oncology care in the USA. He has contributed to several protocols, clinical study reports and safety management plan documents. Over his 15 years  of drug development experience, Akhil has been part of two successful NDAs and four IND filings. He has over ten publications and has received many awards through school and university for academic excellence.

Susanta Samajdar, PhD

Vice President
Medicinal Chemistry

Susanta received his PhD in Synthetic Organic Chemistry from Indian Association for the Cultivation of Science (IACS), Kolkata and subsequently moved to MD Anderson Cancer Center for a Post-Doctoral training on anti-cancer drug discovery. He has over 10 years of synthetic and Medicinal Chemistry research experience in Indian Industries. Susanta has experience in leading multi-disciplinary drug discovery teams that successfully delivered several preclinical development candidates. He has experience in working with various target classes including GPCRs, Ion channels, Proteases, Kinases and NHRs, across different therapeutic areas like Oncology, Pain and Inflammation, Metabolic Disorders and Neurosciences. He has more than 20 publications and patents to his credit. He has been in Aurigene since March 2012

Dr. Shekar Chelur

Research Director
Preclinical Biology

Shekar is a board certified Toxicologist and Toxicologic Pathologist with over 15 years of research experience. He completed his graduate and post graduate studies in Veterinary Pathology from Bangalore Veterinary College. He has worked at Jai Research Foundation, Torrent Research Centre and Zydus Research Centre prior to joining Aurigene in 2004. He has experience in safety evaluation of NCE’s in the area of Metabolic Disorders, Cardiovascular diseases, Oncology, Pain, Inflammatory disorders, Immunomodulators and Musculoskeletal disorders. He is recipient of several merit scholarships including senior research fellowship from Indian Council of Agricultural Research. He is co-inventor of 3 international patents and author of 10 publications.

Thomas Antony, PhD

Research Director
In-Vitro Biology

Thomas received his PhD from University of Delhi and was a Postdoctoral fellow at University of Medicine and Dentistry of New Jersey, USA, and Max Planck Institute for Biophysical Chemistry, Goettingen, Germany. He is a recipient of many research fellowships including UGC Junior and Senior Research Fellowships, Max Planck Fellowship and Alexander Von Humboldt Fellowship. Thomas has extensive drug discovery research experience in the areas of oncology, inflammation, metabolic disorders, and anti-infectives. He has co-authored more than 20 publications in peer-reviewed journals and is co-inventor of 3 international patents.